Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Effective treatment for female pattern hair loss requires identifying and addressing individual factors causing poor response.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

PLA particles release their contents differently based on the type of fluorochrome used.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Excessive sun protection might contribute to frontal fibrosing alopecia.

Trichoscopic features help diagnose and assess female pattern hair loss severity, with inflammation playing a key role.

Female pattern hair loss greatly affects quality of life, especially in younger patients, those with the condition for a long time, and those with mental health issues. A more comprehensive treatment approach is suggested.

Current treatments for postmenopausal frontal fibrosing alopecia stop hair loss but don't regrow hair.

Key genes and pathways control sheep hair growth phases.

Female Pattern Hair Loss is linked to genetics, diet, stress, and certain health conditions.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Scientists made glow-in-the-dark dots from human hair that can detect iron, prevent counterfeiting, and reveal fingerprints.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

A method was developed to isolate and study hair follicle stem cells from mouse skin.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Early onset female hair loss is linked to lower hair density, scalp issues, and certain genetic factors.

Fish collagen peptide may boost hair growth and health.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

10% hPL is best for growing mesenchymal stem cells, while 10% FBS is best for hepatocytes.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

Tremella fuciformis polysaccharide has many health benefits and potential uses in food, medicine, and cosmetics.

Cells from concentrated growth factor can become different cell types.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.